Abstract
Background
Inflammation is implicated in the development of chronic diseases and increases the risk of mortality. People who experience more daily stressors than others have higher levels of inflammation, but it is unknown whether daily positive events are linked to inflammation.
Objective
To examine the association of daily positive events with 3 inflammatory markers, interleukin-6 (IL-6), C-reactive protein (CRP), and fibrinogen.
Method
A cross-sectional sample of 969 adults aged 35–86 from the Midlife in the United States Study completed telephone interviews for 8 consecutive evenings. Participants reported positive experiences that occurred over the past 24 hours. Blood samples were obtained at a separate clinic visit and later assayed for inflammatory markers. Regression analyses evaluated the frequency of daily positive events (defined as the percent of study days with at least 1 positive event) as a predictor of each inflammatory marker. Covariates included information on demographics, physical health, depressive symptoms, dispositional and behavioral factors, and daily positive and negative affect.
Results
On average, participants experienced positive events on 73% of days (SD = 27%). The frequency of daily positive events was associated with lower IL-6 (p < 0.001) and CRP (p = 0.02) in the overall sample, and lower fibrinogen among women (p = 0.01). The association remained for IL-6 in the fully adjusted model, but was no longer significant for CRP and fibrinogen after controlling for household income and race. Effects were more pronounced for participants in the lowest quartile of positive event frequency than for those in the top 3 quartiles, suggesting that lack of positivity in daily life may be particularly consequential for inflammation. Furthermore, interpersonal positive events were more predictive of lower IL-6 overall and lower fibrinogen in women than non-interpersonal positive events.
Conclusion
Daily positive events may serve a protective role against inflammation.
Keywords: daily positive events, uplifts, inflammation, positive affect, negative affect
1. Introduction
Elevated inflammation is implicated in the development of chronic diseases and is a risk factor for mortality in both clinical and population-based samples (1–3). Negative psychological factors—including depression, hostility, and stress—are consistently linked with elevations in inflammatory markers, including the cytokine interleukin-6 (IL-6) and the acute phase proteins C-reactive protein (CRP) and fibrinogen (4–8). Inflammation has bidirectional relationships with psychological distress (9,10) and is therefore likely to play a core mechanistic role linking negative psychological factors to subsequent mental and physical health outcomes.
Although the associations between negative emotions and physiological dysregulation are well-documented, the links between positive psychological factors and inflammation have received less attention. Emerging evidence suggests that indicators of well-being—such as positive affect, purpose in life, and positive social relations—are associated with lower inflammation (11–18) and less inflammatory reactivity during acute stress tasks (19,20). These associations are independent of, and sometimes stronger than, the effects of negative emotions. For example, trait positive affect, but not negative affect, has been linked to lower production of stimulated cytokines in a middle-aged community sample (16). Prospective data from a large cohort of healthy adults showed that, among Black participants, low positive affect uniquely predicted higher CRP five years later but depressive affect did not (12).
Existing studies related to positivity and inflammation have largely relied on trait measures of affect or laboratory tasks that may not fully reflect emotional and stress processes in everyday life. Daily experiences and routine challenges—such as arguments, work deadlines, and family obligations—have immediate effects on emotional and physical functioning, as well as cumulative influences on health. Recent prospective studies have shown that heightened emotional responses to daily stressors are associated with critical outcomes across a decade of follow-up, including increased risks of psychological distress or an affective disorder (21), developing a chronic medical condition (22), and mortality (23). Inflammatory processes are likely to be a key pathway whereby daily experiences influence subsequent health. Indeed, several studies have linked daily stressors to elevated IL-6 and CRP (24–26). Interpersonal events may be especially important for inflammation; for example, daily interpersonal stress is associated with greater stimulated IL-6 production and glucocorticoid resistance among patients with rheumatoid arthritis (27), as well as higher CRP among healthy adolescents (26).
Less is known regarding the potential salutary benefits of minor positive events (also called uplifts) in day-to-day life. Daily positive events, such as having dinner with a friend or taking a leisurely walk, occur more frequently than daily stressors and have differential effects on mood in comparison to daily negative events (28,29). These experiences may influence health over and above the effects of trait positive and negative affect, although this has yet to be empirically tested. Whereas trait affect represents endogenous psychological processes, daily events are exogenous and reflect an individual’s transactions with his or her environment.
In the only existing study of minor positive events and inflammation to our knowledge, the perceived intensity of uplifts was marginally associated with lower IL-6 in a sample of 108 healthy adults (30). The study measured uplifts using a questionnaire that required participants to report on whether specific events had occurred in the past month. However, retrospective measures are susceptible to recall biases and lack the ecological validity of naturalistic methods (e.g., momentary assessments or daily diaries). The question of whether naturally-occurring positive events (assessed in the context of daily life) might influence inflammation remains unanswered.
The primary objective of the current study was to examine the associations between the occurrence of daily positive events and inflammatory markers in a large national sample of midlife and older adults. Daily experiences were measured using daily diary methodology, which assesses events closer to their natural contexts and is better able to capture the richness of everyday life, relative to traditional survey approaches. We utilized 3 markers of inflammation as outcomes: IL-6, CRP, and fibrinogen. Although IL-6 has many anti-inflammatory actions in certain contexts, such as exercise and as a modulator of inflammation in infection (for reviews, see 31,32), it is widely considered proinflammatory in the context of psychological stress; IL-6 as well as CRP and fibrinogen have been robustly linked to cardiovascular disease (33–35) and all have been associated with psychological stress (e.g., 24,36).
Our secondary objective was to describe the associations of inflammatory markers with various aspects of daily positive events (i.e., frequency, type of event, independence from affect). Specifically, we explored non-linear associations among quartiles of positive event frequency, compared the relative contributions of interpersonal versus non-interpersonal daily positive events, and disentangled the inflammatory correlates of daily positive events from those of daily positive affect (PA) and daily negative affect (NA). Our study is the first to report that inflammatory markers are associated with daily positive events, utilizes a large sample using naturalistic methods, and highlights the important role of seemingly minor daily experiences for health and well-being.
2. Methods
2.1. Participants and Design
This study uses cross-sectional data from a subset of participants in the second wave of the Midlife in the United States Study (MIDUS II), conducted between 2004 and 2006. The purpose of MIDUS II was to investigate health and well-being in a national sample of non-institutionalized, English-speaking adults aged 35 to 86 (N = 4,963). An additional 592 African Americans from Milwaukee were recruited to increase the diversity of the study.
A representative subsample of respondents from MIDUS II (N = 2,022) were invited to participate in the National Study of Daily Experiences, which consisted of short telephone interviews about daily experiences for 8 consecutive evenings (37). Of these, 1,001 respondents participated in the MIDUS Biomarker Project. The Biomarker Project required an overnight stay at one of three General Clinical Research Centers (UCLA, Georgetown, and the University of Wisconsin, Madison), where participants provided blood samples and were assessed for physical health and psychophysiological function (38). The order and timing of data collection varied among participants. Data collection for the daily diary and biomarkers were separated by a median of 6 months, with some participants completing the daily diaries before the biomarker assessment and others after. Of the 1,001 participants with biomarker assessments, 19 were missing income data and 13 were missing personality or depressive symptoms data. Thus, the current analyses were conducted on a final sample of 969 adults, including 129 participants from the Milwaukee cohort. Procedures were approved by Institutional Review Boards at participating institutions, and all participants provided informed consent.
2.2. Measures
2.2.1. Predictor: Daily positive events
During telephone interviews for 8 days, participants were asked whether they had experiences that most people would consider particularly positive in the past 24 hours. Five items inquired about events in each of the following life domains: positive interaction, positive experience at work/volunteer position, positive experience at home, network positive event (i.e., positive event experienced by close friend or relative), and any other positive event (39). For instance, positive interactions were assessed by asking, “Did you have an interaction with someone that most people would consider particularly positive (for example, sharing a good laugh with someone, or having a good conversation) since we spoke yesterday?” Participants reported who else was involved in each event (e.g., spouse, child, friend); events where participants were not alone were coded as interpersonal events.
The frequency of positive events was defined as the percent of study days in which at least 1 positive event occurred, based on the number of daily interviews completed (40). There was no difference in the frequency of positive events between those who completed all 8 interviews (N = 684) and those with less than 8 interviews (N = 285). We analyzed the frequency of positive events as both a continuous variable and split into quartiles: Q1: positive events on <57% of days, Q2: 57 – 79%, Q3: 80 – 99%; Q4: 100%. We did not use the raw total number of positive events as the predictor because it does not account for the number of interview days; results were comparable to those reported when the raw number of positive events was entered as a predictor.
2.2.2. Outcome: Inflammatory markers IL-6, CRP, and fibrinogen
Venous blood samples were collected from participants following overnight fasting. Samples were stored in a −65° C freezer until assayed. IL-6 was assayed at the MIDUS Biocore Lab using the Quantikine® high-sensitivity enzyme-linked immunosorbent assay kit (R&D Systems, Minneapolis, MN). Intra-assay and inter-assay coefficients of variation (CV) were <10%. CRP and fibrinogen were assayed at the Laboratory for Clinical Biochemistry Research (University of Vermont, Burlington, VT). CRP was measured using a BN II nephelometer with a particle enhanced immunonephelometric assay. Intra-assay CV was 2.3–4.4% and inter-assay CV was 2.1–5.7%. Fibrinogen was assayed using the Clauss method on a BN II nephelometer (N Antiserum to Human Fibrinogen; Dade Behring Inc., Deerfield, IL). Intra-assay CV for fibrinogen was 2.7% and inter-assay CV was 2.6%. Values of all three biomarkers were natural log-transformed to normalize the distributions.
2.2.3. Covariates
Data on demographics and personality were obtained by telephone and mail surveys, respectively; these surveys were conducted separately from the daily diary and biomarker protocols. The demographic covariates were age, gender, and race (White vs. non-White). Previous research using MIDUS data found that household income (i.e., income from wages, pension, Social Security, and government assistance), but not education level, was independently associated with inflammation (41). Thus, we controlled for household income quintile using the following ranges: Q1: <$24,950; Q2: $24,950–$47,249; Q3: $47,250–$70,499; Q4: $70,500–$105,499; Q5: ≥$105,500.
Prior studies have shown that both negative and positive dispositional factors are linked with inflammatory markers (42–44); therefore, we included neuroticism and optimism as covariates. Participants rated themselves on 4 items for neuroticism (moody, nervous, worrying, calm [reversed]) using a 1-to-4 scale. Ratings were averaged, with higher scores indicating more neuroticism. Optimism was assessed with the 6-item Life Orientation Test-Revised, of which 3 items were positively-worded to measure optimism and 3 items were negatively-worded to measure pessimism (45). Ratings were summed across the 6 items to produce an overall optimism score, with higher scores indicating more optimism (scores ranged from 6 to 30).
As part of the clinic visit for the Biomarker Project, participants provided information on their health status and completed self-reported questionnaires. Height and weight were measured and used to calculate body mass index (BMI); values were natural log-transformed to normalize the distribution. Medical comorbidity was assessed using a checklist of 20 physician-diagnosed chronic conditions (e.g., depression, heart disease, high blood pressure, asthma, diabetes); the total number of chronic conditions was included in the analyses as a continuous variable. Due to the effects of certain medications on inflammatory levels, we controlled for the use of blood pressure, cholesterol-lowering (e.g., statins), corticosteroid, and antidepressant medications. Dummy-coded variables were included to control for current smoking and for regular exercise (defined as engagement in regular exercise or physical activity of any intensity for 20 minutes or more at least 3 times per week). Depressive symptoms were assessed using the 20-item Center for Epidemiological Studies Depression Scale, with higher scores (maximum of 60 points) indicating greater severity (46).
We controlled for daily PA and NA, assessed at the end of each day, to reduce the possibility that any association between daily positive events and inflammation were attributable to affect. Daily affect was assessed using scales developed for the MIDUS study (47,48). Participants reported the frequency of 13 positive emotions (e.g., cheerful, enthusiastic, calm and peaceful) and 14 negative emotions (e.g., nervous, upset, frustrated) using the following 5-point scale: 0 = none of the time, 1 = a little of the time, 2 = some of the time, 3 = most of the time, 4 = all of the time. Daily PA and NA were calculated by averaging the respective items. Across the 8 days, Cronbach’s alpha ranged from 0.93 to 0.95 for daily PA and from 0.84 to 0.88 for daily NA. The mean levels of daily PA and NA were obtained by aggregating scores across all 8 interview days.
2.3. Data analysis
For descriptive purposes, we computed correlations between positive event frequency (i.e., percent of days with ≥1 positive event) and participant demographics, physical health, medication use, and psychological covariates. For our primary analyses, multivariate regression models were run to test positive event frequency as a predictor of each inflammatory marker. The models sequentially controlled for the following covariates: (1) age and gender; (2) household income quintile and White race; (3) log BMI, number of chronic conditions, medication use, smoking status, and regular exercise; and (4) neuroticism, optimism, depressive symptoms, and mean daily PA and NA. We tested interactions between positive event frequency and demographics, BMI, and psychological variables.
We conducted 3 sets of follow-up analyses; these analyses were run using multivariate regression models that controlled for age and gender. First, non-linear associations between positive events and inflammation were evaluated using dummy-coded variables for quartiles of positive event frequency. Second, the percent of days with interpersonal positive events and with non-interpersonal positive events were tested as simultaneous predictors of each inflammatory marker. Finally, mean daily PA and NA were tested separately as predictors of inflammatory markers. Analyses were conducted using SAS version 9.3 (SAS Institute Inc., Cary, NC).
3. Results
3.1. Descriptive findings
Collectively, 969 participants provided 7,212 daily interviews. Participants completed an average of 7.4 interviews (SD = 1.2); 71% of the sample completed all 8 interviews. Participants experienced approximately 1 positive event per day, with a sample median of 8 events across the 8 days of interviewing (range: 0 – 28 total events across 8 days). On average, participants experienced at least 1 positive event on 73% of days (SD = 27%; range: 0–100%).
Sample characteristics and their correlations with daily positive events are shown in Table 1. Fifty-seven percent of the participants were female, and the average age was 58. The racial composition of the sample was 81% White, 15% Black and/or African American, and 4% Native American, Asian American, or other race. Participants had an average of 4 chronic medical conditions, and 40% were obese (i.e., BMI ≥ 30). Those who had a greater frequency of positive events (i.e., percent of days with at least 1 positive event) tended to be older, White, and had higher income and lower BMI. Participants who experienced more frequent daily positive events also had fewer depressive symptoms, less neuroticism, more optimism, higher daily PA, and were less likely to smoke.
Table 1.
Participant Characteristics | Mean (SD) or N (%) | Correlation r with positive event frequencya |
---|---|---|
Demographics | ||
Age | 58 (11.5) | 0.17*** |
Female | 548 (56.6%) | −0.05 |
White race | 789 (81.4%) | 0.16*** |
Household income, median (IQR) | $58,750 ($64,763) | 0.11*** |
Physical Health, Medications, and Health Behaviors | ||
No. of chronic conditions | 4 (2.9) | 0.05 |
Body mass index | 29.66 (6.47) | −0.07* |
Blood pressure medication use | 348 (36%) | −0.01 |
Cholesterol medication use | 271 (28%) | 0.03 |
Corticosteroid medication use | 41 (4%) | −0.05 |
Antidepressant medication use | 137 (14%) | 0.04 |
Current smoker | 129 (13%) | −0.09** |
Regular exercise | 747 (77%) | 0.02 |
Psychological covariates | ||
Depressive symptoms (range: 0 – 60) | 8.53 (8.19) | −0.18*** |
Neuroticism (range: 1 – 4) | 2.03 (0.64) | −0.11*** |
Optimism (range: 6 – 30) | 23.87 (4.71) | 0.26*** |
Daily positive affect (range: 0 – 4) | 2.71 (0.70) | 0.15*** |
Daily negative affect (range: 0 – 4) | 0.21 (0.27) | −0.04 |
p ≤ .001,
p ≤ .01,
p ≤ .05,
p ≤ .10
Positive event frequency was defined as the percent of days in which the participant experienced at least one positive event.
3.2. Daily positive events and inflammation
The median non-transformed levels of inflammatory markers were 2.08 pg/mL for IL-6 (Quartile 1, Quartile 3 [Q1, Q3] = 1.33, 3.38), 1.36 mg/L for CRP (Q1, Q3 = 0.68, 3.39), and 337.00 mg/dL for fibrinogen (Q1, Q3 = 286.00, 394.00). The inflammatory markers had nonnormal distributions and were natural log-transformed for the following analyses.
3.2.1. IL-6
As shown in Table 2, higher positive event frequency predicted lower log IL-6 after controlling for age and gender. The inverse association between the frequency of daily positive events and IL-6 persisted after sequential adjustment for household income and race, physical health (BMI, number of chronic conditions, medication use, smoking, and regular exercise), and psychological covariates (neuroticism, optimism, depressive symptoms, and mean daily PA and NA).
Table 2.
Variable | Log IL-6 (pg/mL, N = 969) Unstandardized B (SE) |
Log CRP (mg/L, N = 966) Unstandardized B (SE) |
Log Fibrinogen in Women (mg/dL, N = 547) Unstandardized B (SE) |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Model 1a | Model 2b | Model 3c | Model 4d | Model 1a | Model 2b | Model 3c | Model 4d | Model 1a | Model 2b | Model 3c | Model 4d | |
Intercept | .82 (.03)*** | 1.14 (.06)*** | 1.06 (.07)*** | 1.07 (.07)*** | .57 (.05)*** | .99 (.10)*** | .84 (.11)*** | .85 (.11)*** | 5.85 (.01)*** | 5.95 (.03)*** | 5.91 (.03)*** | 5.90 (.03)*** |
Positive events | −.33 (.09)*** | −.23 (.09)** | −.19 (.08)* | −.19 (.08)* | −.33 (.14)* | −.21 (.14) | −.14 (.13) | −.18 (.13) | −.11 (.04)** | −.07 (.04) | −.05 (.04) | −.04 (.04) |
Age | .02 (.00)*** | .02 (.00)*** | .01 (.00)*** | .01 (.00)*** | .01 (.00) | .01 (.00) | .01 (.00) | .01 (.00) | .00 (.00)** | .00 (.00)** | .00 (.00)** | .00 (.00)** |
Gender (Ref: Male) | −.10 (.05)* | −.07 (.05) | −.07 (.04)† | −.08 (.04)† | −.44 (.07)*** | −.40 (.07)*** | −.40 (.07)*** | −.39 (.07)*** | — | — | — | — |
Household income | −.05 (.02)** | −.03 (.02)* | −.04 (.02)* | −.05 (.03)† | −.02 (.02) | −.03 (.03) | −.01 (.01) | −.00 (.01) | .00 (.01) | |||
White race | −.30 (.06)*** | −.15 (.06)* | −.15 (.06)** | −.41 (.10)*** | −.10 (.09) | −.10 (.09) | −.11 (.03)*** | −.08 (.03)** | −.07 (.03)* | |||
Log BMI | 1.07 (.11)*** | 1.05 (.11)*** | 2.29 (.17)*** | 2.31 (.17)*** | .34 (.05)*** | .33 (.05)*** | ||||||
Chronic conditions | .01 (.01) | .01 (.01) | .01 (.01) | .01 (.01) | .00 (.00) | .00 (.00) | ||||||
Blood pressure med. | .10 (.05)† | .10 (.05)† | .18 (.08)* | .18 (.08)* | −.01 (.03) | −.01 (.03) | ||||||
Cholesterol med. | −.04 (.05) | −.04 (.05) | −.26 (.08)** | −.27 (.08)*** | −.02 (.03) | −.01 (.03) | ||||||
Corticosteroid med. | −.01 (.10) | −.01 (.10) | −.03 (.16) | −.04 (.16) | −.04 (.05) | −.05 (.05) | ||||||
Antidepressant med. | .13 (.06)* | .13 (.06)* | .15 (.10) | .15 (.10) | .03 (.03) | .02 (.03) | ||||||
Current smoker | .13 (.06)* | .14 (.06)* | .17 (.10)† | .19 (.10)† | .04 (.03) | .04 (.03) | ||||||
Regular exercise | −.16 (.05)** | −.16 (.05)** | −.23 (.08)** | −.24 (.08)** | .00 (.03) | .01 (.03) | ||||||
Neuroticism | −.04 (.04) | .05 (.07) | −.03 (.02) | |||||||||
Optimism | .00 (.01) | .02 (.01)† | .00 (.00) | |||||||||
Depressive symptoms | .00 (.00) | .00 (.01) | .00 (.00) | |||||||||
Mean daily PA | −.02 (.04) | .02 (.06) | .01 (.02) | |||||||||
Mean daily NA | −.10 (.10) | .01 (.15) | .04 (.05) |
p ≤ .001,
p ≤ .01,
p ≤ .05,
p ≤ .10
Model 1 contains age and gender as covariates.
Model 2 includes additional covariates for race and household income quintile.
Model 3 includes additional covariates for physical health, medication use, and health behaviors.
Model 4 includes additional covariates for psychological factors and mean daily affect.
There was a significant interaction between positive event frequency and household income quintile in predicting IL-6 (p = 0.02 for interaction in fully adjusted model). IL-6 did not differ based on positive event frequency among participants with higher income; however, more frequent daily positive events were associated with relatively lower IL-6 among participants with lower income. Positive event frequency did not interact with mean levels of daily PA or daily NA (fully adjusted p = 0.79 and p = 0.37, respectively), nor did it interact with BMI or other demographic and psychological characteristics to predict IL-6.
3.2.2. CRP
Greater frequency of daily positive events predicted lower log CRP, controlling for age and gender (Table 2). This association was reduced to non-significance after controlling for household income and race. Positive event frequency interacted with mean levels of daily NA in determining CRP, such that more frequent positive events was associated with lower CRP only among participants with lower NA but not for participants with higher NA (p = 0.01 for interaction in fully adjusted model). Positive event frequency did not interact with mean levels of daily PA in predicting CRP (fully adjusted p = 0.39), nor did it interact with demographics, BMI, or other psychological characteristics.
3.2.3. Fibrinogen
Positive event frequency did not predict log fibrinogen in an age- and gender-adjusted model (b = −0.04, SE = 0.03, p = 0.19). However, there was a significant interaction between positive event frequency and gender (b = 0.15, SE = 0.06, p = 0.02), such that higher frequency of daily positive events was associated with lower fibrinogen among women (n = 547; p = 0.01) but not men (n = 419; p = 0.41). Table 2 shows the results of multivariate models for women only. After controlling for household income and race, positive event frequency was no longer associated with fibrinogen among women. No interaction effects were significant after controlling for covariates, either in gender-stratified models or as 3-way interactions in the sample as a whole (i.e., positive event frequency x gender x participant characteristic).
3.3. Secondary analyses
3.3.1. Non-linear associations
In regression models testing quartiles of positive event frequency as predictors, participants in the lowest quartile (positive events on <57% of days) had marginally higher log IL-6 than the second quartile (positive events on 57 – 79% of days; b = −0.12, SE = 0.06, p = 0.055) and significantly higher IL-6 than the third quartile (positive events on 80 – 99% of days; b = −0.20, SE = 0.07, p = 0.003) and the fourth quartile (positive events every day; b = −0.23, SE = 0.06, p < 0.001), controlling for age and gender (Figure 1). The top three positive event quartiles did not differ significantly from one another in IL-6. Compared to the highest quartile, log CRP was elevated among participants in the lowest quartile (b = 0.21, SE = 0.10, p = 0.04) and in the second quartile (b = 0.23, SE = 0.10, p = 0.02), but no different for the third quartile (b = 0.06, SE = 0.11, p = 0.59), controlling for age and gender. Fibrinogen did not differ among quartiles for the sample as a whole; however, in women only, the lowest quartile of positive event frequency had higher log fibrinogen than the third quartile (age-adjusted b = −0.07, SE = 0.03, p = 0.045) and the fourth quartile (age-adjusted b = −0.07, SE = 0.03, p = 0.04).
3.3.2. Interpersonal versus non-interpersonal positive events
On average, participants experienced interpersonal positive events on 71% of days (SD = 27%) and non-interpersonal positive events on 9% of days (SD = 15%). The frequency of interpersonal positive events was associated with lower log IL-6 (b = −0.28, SE = 0.09, p = 0.001) but this association did not reach significance for CRP (b = −0.26, SE = 0.14, p = 0.066), controlling for age, gender, and non-interpersonal events. Among women only, frequency of interpersonal positive events predicted lower fibrinogen, independent of age and non-interpersonal events (b = −0.10, SE = 0.04, p = 0.02). The associations of daily interpersonal positive events with IL-6 and with fibrinogen in women were no longer significant in fully adjusted models. Non-interpersonal positive events were not associated with any inflammatory markers, either alone or after controlling for interpersonal positive events.
3.3.3. Affect
Daily PA and NA were not associated with any of the 3 inflammatory markers in unadjusted or adjusted models.
4. Discussion
This study is the first to show that daily positive events, assessed in the context of day-to-day life, are associated with inflammatory markers. In a national sample of 969 midlife and older adults, those who experienced frequent minor positive events tended to have relatively lower IL-6 and CRP, as well as lower fibrinogen among women. The association between frequency of daily positive events and IL-6 persisted after accounting for a range of potential confounding variables, suggesting that even seemingly minor daily experiences are consequential for health.
Our study adds to the growing evidence base linking positive psychological factors to lower levels of inflammation (11,13–20). Previous studies have focused on stable psychological characteristics and psychosocial resources (e.g., positive affect and social relations); our study extends these findings by demonstrating the importance of daily events on inflammation. Indeed, recent studies suggest that daily stressors accumulate over time to influence physical and mental health outcomes (21–26). One previous study of 108 healthy younger adults (mean age of 36) showed that daily positive experiences were marginally associated with lower IL-6 (30). In contrast, our study may have found significant effects due to the larger sample size, inclusion of participants regardless of medical comorbidities, greater age-related variability in inflammation, and use of daily diary methodology for assessing daily events.
The links between daily positive events and inflammatory markers were explained or moderated by socioeconomic status and gender. Specifically, the findings for CRP and fibrinogen were accounted for by race and household income. In line with previous research on health disparities, White participants had significantly lower BMI and lower levels of all 3 inflammatory markers relative to non-White (primarily African American or Black) participants. White participants in our sample had more positive experiences in their daily lives; they reported positive events on 75% of days, compared to 64% for non-White participants. Yet, daily positive events may have represented a source of resilience that protected against the influence of economic disadvantage on IL-6. High-income participants did not differ in IL-6 based on their frequency of positive events, whereas low-income participants who experienced more frequent positive events had lower IL-6 than their counterparts who had fewer positive events. Prior studies have uncovered similar trends, in which positive aspects of psychological well-being (e.g., purpose in life, social relations) buffered against the detrimental effects of low educational attainment and medical comorbidities on inflammation (13,49). Furthermore, there were gender differences in the association between daily positive events and fibrinogen. Our finding that positive event frequency was associated with lower fibrinogen only among women was consistent with a study of the Whitehall II cohort, in which positive affect was inversely associated with inflammatory markers among women but not men (17). Further work is needed to understand racial, socioeconomic, and gender differences in the role of daily experiences on health.
Notably, there was not a clear dose-response relationship between daily positive events and inflammatory markers. The effects were most pronounced among participants in the lowest quartile of positive event frequency (<57% of days), whose average anti-logged IL-6 level was 0.30 pg/mL higher than those in the top 3 quartiles of positive event frequency. In contrast, average IL-6 levels only varied by 0.01–0.11 pg/mL among the top 3 quartiles. Thus, consistent with past research (12), lack of positivity appears to be particularly important for inflammation.
Prior research has found that social support and interpersonal interactions are important for health and well-being. As expected, we found that interpersonal positive events predicted lower IL-6 in the entire sample and lower fibrinogen in women, but non-interpersonal positive events were not associated with inflammatory markers. However, the findings for daily positive events as a whole were stronger than those for interpersonal events alone, indicating that interpersonal events are not the only type of positive experiences that are important for inflammation. The potential health effects of different types of positive experiences, their intensity, and subjective appraisals, are all topics that deserve further study.
Unlike previous research, positive and negative affect did not predict inflammation in the current study. Prior studies have primarily used measures of stable, recollected affect, in which participants rated their affect in general or over a specified period (e.g., past 2 weeks), whereas the present research used an aggregate measure of daily affect across 8 days. Recollected affect may differ from actual experience of affect because it is susceptible to memory biases and global evaluations of one’s life (50). Few studies have compared momentary or daily measures of affect versus recollected measures for predicting physiological functioning (51,52). There was a moderating effect of daily NA in our study, whereby positive event frequency was associated with lower CRP only among participants with lower NA but not for those with higher NA. The positive events reported by participants were minor and common in daily life, such as gardening, spending time with family, or having a pleasant conversation; these experiences were perhaps not potent enough to counteract the inflammatory effects of frequent negative emotions (which occurred independent of trait neuroticism, optimism/pessimism, and depressive symptoms).
The mechanisms linking daily positive events to inflammation are unclear. The association was not explained by mean daily affect, suggesting that the findings were not merely driven by overall levels of affect. However, participants’ perceptions of the events were not obtained. Our measures of end-of-day affect (aggregated across interview days) may have lacked the temporal sensitivity for capturing small changes in affect in response to the positive events. Momentary assessments would be ideal for examining affective reactions, perceptions, and contexts surrounding minor positive events in everyday life. Alternatively, positive psychological factors have been linked to better health behaviors that are consequential for inflammation, including non-smoking, physical activity, moderate alcohol consumption, and prudent dietary choices (53,54). Our measures of smoking and exercise were associated with inflammatory markers in the predicted directions, but they were not precise enough to examine the momentary coupling of positive experiences and health behaviors. Finally, daily positive events may be linked to lower inflammation via its role in stress processes. Daily stress elicits secretion of glucocorticoids, including cortisol (55); persistently high cortisol output can lead to down-regulation of glucocorticoid receptors that subsequently diminishes the sensitivity of the immune system to cortisol’s anti-inflammatory effects (9). Positive psychological factors have been shown to undo the physiological effects of stress (56), enhance cognitive flexibility (e.g., creative problem-solving) and psychosocial resources for coping with stress (57), and reduce physiological reactivity to stressors (19,20).
Our study was limited in several ways. First, the MIDUS sample is more affluent and educated than the general population. Caution should be taken in generalizing the results to other samples. Second, this study was cross-sectional and therefore causal conclusions cannot be drawn regarding the directionality of the association between daily positive events and inflammation. Laboratory studies suggest that positive affect predicts lower inflammatory responses to stress tasks (19,20); yet, other research has shown that elevated inflammation induces depressed mood and sickness behaviors that may subsequently impair daily functioning (10). Future studies using a longitudinal design and multiple assessments of inflammation are needed to better understand the role of daily experiences in inflammation.
In summary, the current study is the first to provide evidence that daily positive experiences are associated with lower levels of inflammation among midlife and older adults. Our study expands upon the literature on positivity and health, by demonstrating that exogenous positive experiences may be just as consequential for physiological functioning as trait positive affect and other positive psychological factors. These findings underscore the importance of examining positive aspects of day-to-day life, which are far more common than negative events and may accumulate over time to influence long-term health.
Acknowledgments
This research was supported by a grant from the National Institute on Aging (P01-AG020166) to conduct a longitudinal follow-up of the MIDUS (Midlife in the U.S.) investigation. The original study was supported by the John D. and Catherine T. MacArthur Foundation Research Network on Successful Midlife Development.
We thank the staff of the Clinical Research Centers at the University of Wisconsin-Madison, UCLA, and Georgetown University for their support in conducting this study. The MIDUS Biomarker Project was supported by the following grants: M01-RR023942 (Georgetown), M01-RR00865 (UCLA) from the General Clinical Research Centers Program and 1UL1RR025011 (UW) from the Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources, National Institutes of Health. The funding sources had no involvement in the study design; data collection, analysis, or interpretation; nor the writing and submission of this manuscript.
Footnotes
Conflict of Interest
The authors have no conflicts of interest to disclose.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH, Jr, et al. Associations of elevated Interleukin-6 and C-Reactive protein levels with mortality in the elderly. Am J Med. 1999;106(5):506–12. doi: 10.1016/s0002-9343(99)00066-2. [DOI] [PubMed] [Google Scholar]
- 2.Reuben DB, Cheh AI, Harris TB, Ferrucci L, Rowe JW, Tracy RP, et al. Peripheral Blood Markers of Inflammation Predict Mortality and Functional Decline in High-Functioning Community-Dwelling Older Persons. J Am Geriatr Soc. 2002;50(4):638–44. doi: 10.1046/j.1532-5415.2002.50157.x. [DOI] [PubMed] [Google Scholar]
- 3.Volpato S, Guralnik JM, Ferrucci L, Balfour J, Chaves P, Fried LP, et al. Cardiovascular Disease, Interleukin-6, and Risk of Mortality in Older Women The Women’s Health and Aging Study. Circulation. 2001;103(7):947–53. doi: 10.1161/01.cir.103.7.947. [DOI] [PubMed] [Google Scholar]
- 4.Duivis HE, de Jonge P, Penninx BW, Na BY, Cohen BE, Whooley MA. Depressive Symptoms, Health Behaviors, and Subsequent Inflammation in Patients With Coronary Heart Disease: Prospective Findings From the Heart and Soul Study. Am J Psychiatry. 2011;168(9):913–20. doi: 10.1176/appi.ajp.2011.10081163. [DOI] [PubMed] [Google Scholar]
- 5.Glaser R, Robles TF, Sheridan J, Malarkey WB, Kiecolt-Glaser JK. Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults. Arch Gen Psychiatry. 2003;60(10):1009–14. doi: 10.1001/archpsyc.60.10.1009. [DOI] [PubMed] [Google Scholar]
- 6.Howren MB, Lamkin DM, Suls J. Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis. Psychosom Med. 2009;71(2):171–86. doi: 10.1097/PSY.0b013e3181907c1b. [DOI] [PubMed] [Google Scholar]
- 7.Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci. 2003;100(15):9090–5. doi: 10.1073/pnas.1531903100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Steptoe A, Hamer M, Chida Y. The effects of acute psychological stress on circulating inflammatory factors in humans: A review and meta-analysis. Brain Behav Immun. 2007 Oct;21(7):901–12. doi: 10.1016/j.bbi.2007.03.011. [DOI] [PubMed] [Google Scholar]
- 9.Miller GE, Cohen S, Ritchey AK. Chronic psychological stress and the regulation of proinflammatory cytokines: A glucocorticoid-resistance model. Health Psychol. 2002;21(6):531–41. doi: 10.1037//0278-6133.21.6.531. [DOI] [PubMed] [Google Scholar]
- 10.Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46–56. doi: 10.1038/nrn2297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Brouwers C, Mommersteeg PMC, Nyklček I, Pelle AJ, Westerhuis BLWJJM, Szabó BM, et al. Positive affect dimensions and their association with inflammatory biomarkers in patients with chronic heart failure. Biol Psychol. 2013;92(2):220–6. doi: 10.1016/j.biopsycho.2012.10.002. [DOI] [PubMed] [Google Scholar]
- 12.Deverts DJ, Cohen S, DiLillo VG, Lewis CE, Kiefe C, Whooley M, et al. Depressive symptoms, race, and circulating C-reactive protein: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Psychosom Med. 2010;72(8):734–41. doi: 10.1097/PSY.0b013e3181ec4b98. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Friedman EM, Ryff CD. Living well with medical comorbidities: a biopsychosocial perspective. J Gerontol B Psychol Sci Soc Sci. 2012;67(5):535–44. doi: 10.1093/geronb/gbr152. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Friedman EM, Hayney MS, Love GD, Urry HL, Rosenkranz MA, Davidson RJ, et al. Social relationships, sleep quality, and interleukin-6 in aging women. Proc Natl Acad Sci U S A. 2005;102(51):18757–62. doi: 10.1073/pnas.0509281102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Friedman EM, Hayney M, Love GD, Singer BH, Ryff CD. Plasma interleukin-6 and soluble IL-6 receptors are associated with psychological well-being in aging women. Health Psychol. 2007;26(3):305–13. doi: 10.1037/0278-6133.26.3.305. [DOI] [PubMed] [Google Scholar]
- 16.Prather AA, Marsland AL, Muldoon MF, Manuck SB. Positive affective style covaries with stimulated IL-6 and IL-10 production in a middle-aged community sample. Brain Behav Immun. 2007;21(8):1033–7. doi: 10.1016/j.bbi.2007.04.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Steptoe A, O’Donnell K, Badrick E, Kumari M, Marmot M. Neuroendocrine and Inflammatory Factors Associated with Positive Affect in Healthy Men and Women The Whitehall II Study. Am J Epidemiol. 2008 Jan 1;167(1):96–102. doi: 10.1093/aje/kwm252. [DOI] [PubMed] [Google Scholar]
- 18.Von Känel R, Mausbach BT, Dimsdale JE, Mills PJ, Patterson TL, Ancoli-Israel S, et al. Ways of coping and biomarkers of an increased atherothrombotic cardiovascular disease risk in elderly individuals. Cardiovasc Psychiatry Neurol. 2012;2012:1–9. doi: 10.1155/2012/875876. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Aschbacher K, Epel E, Wolkowitz OM, Prather AA, Puterman E, Dhabhar FS. Maintenance of a positive outlook during acute stress protects against pro-inflammatory reactivity and future depressive symptoms. Brain Behav Immun. 2012;26(2):346–52. doi: 10.1016/j.bbi.2011.10.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Steptoe A, Wardle J, Marmot M. Positive affect and health-related neuroendocrine, cardiovascular, and inflammatory processes. Proc Natl Acad Sci U S A. 2005;102(18):6508–12. doi: 10.1073/pnas.0409174102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Charles ST, Piazza JR, Mogle J, Sliwinski MJ, Almeida DM. The Wear and Tear of Daily Stressors on Mental Health. Psychol Sci. 2013;24(5):733–41. doi: 10.1177/0956797612462222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Piazza JR, Charles ST, Sliwinski MJ, Mogle J, Almeida DM. Affective reactivity to daily stressors and long-term risk of reporting a chronic physical health condition. Ann Behav Med. 2013;45(1):110–20. doi: 10.1007/s12160-012-9423-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Mroczek DK, Stawski RS, Turiano NA, Chan W, Almeida DM, Neupert SD, et al. Emotional Reactivity and Mortality: Longitudinal Findings From the VA Normative Aging Study. J Gerontol B Psychol Sci Soc Sci. 2013:1–9. doi: 10.1093/geronb/gbt107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Gouin J-P, Glaser R, Malarkey WB, Beversdorf D, Kiecolt-Glaser J. Chronic stress, daily stressors, and circulating inflammatory markers. Health Psychol. 2012;31(2):264–8. doi: 10.1037/a0025536. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Gouin J-P, Glaser R, Malarkey WB, Beversdorf D, Kiecolt-Glaser JK. Childhood Abuse and Inflammatory Responses to Daily Stressors. Ann Behav Med. 2012;44(2):287–92. doi: 10.1007/s12160-012-9386-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Fuligni AJ, Telzer EH, Bower J, Cole SW, Kiang L, Irwin MR. A Preliminary Study of Daily Interpersonal Stress and C-Reactive Protein Levels Among Adolescents From Latin American and European Backgrounds. Psychosom Med. 2009;71(3):329–33. doi: 10.1097/PSY.0b013e3181921b1f. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Davis MC, Zautra AJ, Younger J, Motivala SJ, Attrep J, Irwin MR. Chronic stress and regulation of cellular markers of inflammation in rheumatoid arthritis: Implications for fatigue. Brain Behav Immun. 2008;22(1):24–32. doi: 10.1016/j.bbi.2007.06.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Zautra AJ, Affleck GG, Tennen H, Reich JW, Davis MC. Dynamic approaches to emotions and stress in everyday life: Bolger and Zuckerman reloaded with positive as well as negative affects. J Pers. 2005;73(6):1511–38. doi: 10.1111/j.0022-3506.2005.00357.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Zautra AJ, Reich JW. Life events and perceptions of life quality: Developments in a two-factor approach. J Community Psychol. 1983;11(2):121–32. [Google Scholar]
- 30.Jain S, Mills PJ, Von Känel R, Hong S, Dimsdale JE. Effects of perceived stress and uplifts on inflammation and coagulability. Psychophysiology. 2007;44(1):154–60. doi: 10.1111/j.1469-8986.2006.00480.x. [DOI] [PubMed] [Google Scholar]
- 31.Hawkley LC, Bosch JA, Engeland CG, Cacioppo JT, Marucha PT. Loneliness, dysphoria, stress, and immunity: A role for cytokines. In: Plotnikoff NP, Faith RE, Murgo AJ, editors. Stress and immunity. Boca Raton: CRC Press; 2007. pp. 67–80. [Google Scholar]
- 32.Woods JA, Vieira VJ, Keylock KT. Exercise, Inflammation, and Innate Immunity. Immunol Allergy Clin North Am. 2009;29(2):381–93. doi: 10.1016/j.iac.2009.02.011. [DOI] [PubMed] [Google Scholar]
- 33.Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, et al. C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease. N Engl J Med. 2004;350(14):1387–97. doi: 10.1056/NEJMoa032804. [DOI] [PubMed] [Google Scholar]
- 34.Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. Markers of Inflammation and Cardiovascular Disease Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499–511. doi: 10.1161/01.cir.0000052939.59093.45. [DOI] [PubMed] [Google Scholar]
- 35.Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis. 2000 Feb 1;148(2):209–14. doi: 10.1016/s0021-9150(99)00463-3. [DOI] [PubMed] [Google Scholar]
- 36.Wium-Andersen MK, Ørsted DD, Nordestgaard BG. Elevated plasma fibrinogen, psychological distress, antidepressant use, and hospitalization with depression: Two large population-based studies. Psychoneuroendocrinology. 2013;38(5):638–47. doi: 10.1016/j.psyneuen.2012.08.006. [DOI] [PubMed] [Google Scholar]
- 37.Almeida DM, McGonagle K, King H. Assessing daily stress processes in social surveys by combining stressor exposure and salivary cortisol. Biodemography Soc Biol. 2009;55(2):219–37. doi: 10.1080/19485560903382338. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Love GD, Seeman TE, Weinstein M, Ryff CD. Bioindicators in the MIDUS national study: protocol, measures, sample, and comparative context. J Aging Health. 2010;22(8):1059–80. doi: 10.1177/0898264310374355. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Charles ST, Luong G, Almeida DM, Ryff C, Sturm M, Love G. Fewer ups and downs: Daily stressors mediate age differences in negative affect. J Gerontol B Psychol Sci Soc Sci. 2010;65B(3):279–86. doi: 10.1093/geronb/gbq002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Seltzer MM, Almeida DM, Greenberg JS, Savla J, Stawski RS, Hong J, et al. Psychosocial and Biological Markers of Daily Lives of Midlife Parents of Children with Disabilities. J Health Soc Behav. 2009;50(1):1–15. doi: 10.1177/002214650905000101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Friedman EM, Herd P. Income, Education, and Inflammation: Differential Associations in a National Probability Sample (The MIDUS Study) Psychosom Med. 2010;72(3):290–300. doi: 10.1097/PSY.0b013e3181cfe4c2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Marsland AL, Prather AA, Petersen KL, Cohen S, Manuck SB. Antagonistic characteristics are positively associated with inflammatory markers independently of trait negative emotionality. Brain Behav Immun. 2008;22(5):753–61. doi: 10.1016/j.bbi.2007.11.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Roy B, Diez-Roux AV, Seeman T, Ranjit N, Shea S, Cushman M. The association of optimism and pessimism with inflammation and hemostasis in the Multi-Ethnic Study of Atherosclerosis (MESA) Psychosom Med. 2010;72(2):134. doi: 10.1097/PSY.0b013e3181cb981b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Ikeda A, Schwartz J, Peters JL, Fang S, Spiro A, Sparrow D, et al. Optimism in relation to inflammation and endothelial dysfunction in older men: the VA Normative Aging Study. Psychosom Med. 2011;73(8):664–71. doi: 10.1097/PSY.0b013e3182312497. [DOI] [PubMed] [Google Scholar]
- 45.Scheier MF, Carver CS, Bridges MW. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test. J Pers Soc Psychol. 1994;67(6):1063–78. doi: 10.1037//0022-3514.67.6.1063. [DOI] [PubMed] [Google Scholar]
- 46.Radloff LS. The CES-D Scale A Self-Report Depression Scale for Research in the General Population. Appl Psychol Meas. 1977;1(3):385–401. [Google Scholar]
- 47.Kessler RC, Andrews G, Colpe LJ, Hiripi E, Mroczek DK, Normand SLT, et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med. 2002;32(6):959–76. doi: 10.1017/s0033291702006074. [DOI] [PubMed] [Google Scholar]
- 48.Mroczek DK, Kolarz CM. The effect of age on positive and negative affect: A developmental perspective on happiness. J Pers Soc Psychol. 1998;75(5):1333–49. doi: 10.1037//0022-3514.75.5.1333. [DOI] [PubMed] [Google Scholar]
- 49.Morozink JA, Friedman EM, Coe CL, Ryff CD. Socioeconomic and psychosocial predictors of interleukin-6 in the MIDUS national sample. Health Psychol. 2010;29(6):626. doi: 10.1037/a0021360. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Kahneman D, Riis J. Living, and thinking about it: Two perspectives on life. Sci Well-Being. 2005:285–304. [Google Scholar]
- 51.Daly M. Are momentary measures of positive affect better predictors of mortality than recalled feelings? Proc Natl Acad Sci. 2012;109(18):E1049–E1049. doi: 10.1073/pnas.1201630109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Steptoe A, Leigh Gibson E, Hamer M, Wardle J. Neuroendocrine and cardiovascular correlates of positive affect measured by ecological momentary assessment and by questionnaire. Psychoneuroendocrinology. 2007;32(1):56–64. doi: 10.1016/j.psyneuen.2006.10.001. [DOI] [PubMed] [Google Scholar]
- 53.Grant N, Wardle J, Steptoe A. The relationship between life satisfaction and health behavior: a cross-cultural analysis of young adults. Int J Behav Med. 2009;16(3):259–68. doi: 10.1007/s12529-009-9032-x. [DOI] [PubMed] [Google Scholar]
- 54.Steptoe A, Wright C, Kunz-Ebrecht SR, Iliffe S. Dispositional optimism and health behaviour in community-dwelling older people: associations with healthy ageing. Br J Health Psychol. 2006;11(Pt 1):71–84. doi: 10.1348/135910705X42850. [DOI] [PubMed] [Google Scholar]
- 55.Stawski RS, Cichy KE, Piazza JR, Almeida DM. Associations among daily stressors and salivary cortisol: Findings from the National Study of Daily Experiences. Psychoneuroendocrinology. 2013;38(11):2654–65. doi: 10.1016/j.psyneuen.2013.06.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Fredrickson BL, Mancuso RA, Branigan C, Tugade MM. The undoing effect of positive emotions. Motiv Emot. 2000;24(4):237–58. doi: 10.1023/a:1010796329158. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Fredrickson BL. What good are positive emotions? Rev Gen Psychol. 1998;2(3):300–19. doi: 10.1037/1089-2680.2.3.300. [DOI] [PMC free article] [PubMed] [Google Scholar]